Publications by authors named "Y Hammoud"

Purpose: Radiotherapy quality assurance (RTQA) is essential for ensuring adherence to trial protocols. This paper summarizes the individual case review (ICR) results from the PEACE-1 trial, a phase-III study investigates standard of care (androgen deprivation therapy with or without docetaxel) with or without local radiotherapy; and with or without abiraterone acetate plus prednisone in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Materials And Methods: Participating institutions submitted radiotherapy (RT) plans for central review, assessing protocol compliance in target volume and organs at risk (OARs) delineation, as well as dose specifications.

View Article and Find Full Text PDF

Background: Chemoradiotherapy with high-dose cisplatin (HD-Cis: 100 mg/m q3w for three cycles) is the standard of care (SOC) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Cumulative delivered dose of cisplatin is prognostic of survival, even beyond 200 mg/m but high toxicity compromises its delivery.

Aim: Cisplatin fractionation may allow, by decreasing the peak serum concentration, to decrease toxicity.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how inflammation, represented by neutrophil-to-lymphocyte ratio (NLR) and neutrophil count (PNN), impacts survival outcomes in patients with localized bladder cancer undergoing chemoradiation.
  • - Analyzed data from 194 patients showed that those with high NLR (above 2.6) and elevated PNN (above 4000/mm) experienced significantly lower overall survival (OS) and progression-free survival (PFS).
  • - While high PNN was a strong indicator of poor OS and PFS outcomes, NLR did not prove to be an independent prognostic factor in this analysis.
View Article and Find Full Text PDF

Purpose: To assess the efficacy and the tolerance of a split course hypofractionated (SCH) radiotherapy (RT) protocol in head and neck cancer (HNC) for eldery and/or unfit patients (pts).

Patients And Methods: Pts with HNC treated by SCH-RT in two institutions were included retrospectively. The main SCH RT regimen was two courses of 30 grays (Gy)/10 fractions separated by 2-4 weeks, without any systemic therapy.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to validate the Diabetes Medication Adherence Scale (DMAS-7) by comparing it to another established scale (LMAS-14) and identifying factors that influence medication adherence among diabetic patients in Lebanon.
  • - Conducted on 300 diabetic patients, results revealed a 33.7% adherence rate, with DMAS-7 showing good reliability and strong correlation with LMAS-14, indicating it might be a more effective tool for measuring adherence.
  • - The findings suggest that achieving optimal glycated hemoglobin levels and engaging in regular physical activity significantly enhance medication adherence, making DMAS-7 a valuable resource for improving diabetes management.
View Article and Find Full Text PDF